Ketamine for the treatment of major depression: a systematic review and meta-analysis

BACKGROUND: Intranasal esketamine has received regulatory approvals for the treatment of depression. Recently a large trial of repeated dose racemic ketamine also demonstrated efficacy in severe depression. However, uncertainties remain regarding comparative efficacy, dosage, and the time course of...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolin, Stevan, Rodgers, Anthony, Schwaab, Andreas, Bahji, Anees, Zarate, Carlos, Vazquez, Gustavo, Loo, Colleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430179/
https://www.ncbi.nlm.nih.gov/pubmed/37593223
http://dx.doi.org/10.1016/j.eclinm.2023.102127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430179/
https://www.ncbi.nlm.nih.gov/pubmed/37593223
http://dx.doi.org/10.1016/j.eclinm.2023.102127

Ejemplares similares